Premium
High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry
Author(s) -
Groseclose M. Reid,
Massion Pierre P.,
Chaurand Pierre,
Caprioli Richard M.
Publication year - 2008
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.200800495
Subject(s) - tissue microarray , mass spectrometry imaging , pathology , maldi imaging , h&e stain , proteomics , mass spectrometry , adenocarcinoma , cancer , medicine , biology , computational biology , immunohistochemistry , chemistry , matrix assisted laser desorption/ionization , chromatography , gene , biochemistry , organic chemistry , adsorption , desorption
A novel method for high‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded (FFPE) tissue microarrays (TMA) is described using on‐tissue tryptic digestion followed by MALDI imaging MS. A TMA section containing 112 needle core biopsies from lung‐tumor patients was analyzed using MS and the data were correlated to a serial hematoxylin and eosin (H&E)‐stained section having various histological regions marked, including cancer, non‐cancer, and normal ones. By correlating each mass spectrum to a defined histological region, statistical classification models were generated that can sufficiently distinguish biopsies from adenocarcinoma from squamous cell carcinoma biopsies. These classification models were built using a training set of biopsies in the TMA and were then validated on the remaining biopsies. Peptide markers of interest were identified directly from the TMA section using MALDI MS/MS sequence analysis. The ability to detect and characterize tumor marker proteins for a large cohort of FFPE samples in a high‐throughput approach will be of significant benefit not only to investigators studying tumor biology, but also to clinicians for diagnostic and prognostic purposes.